Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicity.
about
Exercise Prevention of Cardiovascular Disease in Breast Cancer SurvivorsUsing exercise to measure and modify cardiac functionEffects of doxorubicin on cardiac muscle subsarcolemmal and intermyofibrillar mitochondria.Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice.Short-term exercise training protects against doxorubicin-induced cardiac mitochondrial damage independent of HSP72.Modulation of anthracycline-induced cardiotoxicity by aerobic exercise in breast cancer: current evidence and underlying mechanisms.Exercise therapy in the management of solid tumors.Increased Nitric Oxide Bioavailability and Decreased Sympathetic Modulation Are Involved in Vascular Adjustments Induced by Low-Intensity Resistance Training.Recent advances in protection against doxorubicin-induced toxicity.Trastuzumab and doxorubicin-related cardiotoxicity and the cardioprotective role of exercise.Doxorubicin inhibits muscle inflammation after eccentric exercise.Exercise-induced cardiac preconditioning: how exercise protects your achy-breaky heart.Exercise-induced improvements in myocardial antioxidant capacity: the antioxidant players and cardioprotection.Modulatory Effect of Aerobic Exercise Training on Doxorubicin-Induced Cardiotoxicity in Rats with Different Ages.Cardiomyopathic Toxicity From Chemotherapy: Is There an Opportunity for Preemptive Intervention?Cardiac complications of chemotherapy: role of prevention.The Role of MicroRNAs in the Cardiac Response to Exercise.Curing the cure: utilizing exercise to limit cardiotoxicity.Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1.Anandamide preserves cardiac function and geometry in an acute doxorubicin cardiotoxicity rat model.The Positive Effects of Exercise in Chemotherapy-Related Cardiomyopathy.Cardiac Aging - Benefits of Exercise, Nrf2 Activation and Antioxidant Signaling.Research priorities in cancer cachexia: The University of Rochester Cancer Center NCI Community Oncology Research Program Research Base Symposium on Cancer Cachexia and Sarcopenia.The decrease of NAD(P)H:quinone oxidoreductase 1 activity and increase of ROS production by NADPH oxidases are early biomarkers in doxorubicin cardiotoxicity.Effects of voluntary wheel running on cardiac function and myosin heavy chain in chemically gonadectomized rats.Tissue retention of doxorubicin and its effects on cardiac, smooth, and skeletal muscle function.Effects of doxorubicin administration on bone strength and quality in sedentary and physically active Wistar rats.Effects of Chronic Endurance Exercise on Doxorubicin-Induced Thymic Damage.A Focused Review of Safety Considerations in Cancer Rehabilitation.Doxorubicin-induced markers of myocardial autophagic signaling in sedentary and exercise trained animals.Rehabilitative exercise in a rat model of doxorubicin cardiotoxicity.Effects of endurance training on combined goserelin acetate and doxorubicin treatment-induced cardiac dysfunction.Effects of resveratrol, exercises and their combination on gene expression and apoptosis in the liver of elderly rats with nonalcoholic fatty liverAcute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats
P2860
Q26785410-3EA129EC-64C0-471F-B9AC-FA543698E14BQ26994995-48D5745C-701B-4714-8EC6-41B7EC8748F1Q33649513-4671F987-9AF6-4920-8254-22D53105E696Q33976440-9381F804-6E63-4315-B78D-E86DE31F208FQ34357604-29C41288-1724-424F-B4AC-D0D8C14F0338Q35158082-F7B63311-E687-4C80-889A-F711FE46EFB1Q36747239-4F56D38D-5FF2-47AC-8FF6-DA92B74426D5Q37043286-7D574D86-137B-4586-9EDC-82CEB2EE64F1Q37338134-331F583A-56CB-4553-B853-5C4C501905F0Q37378906-F86A0113-C4AA-42CF-B298-2422C6964540Q37734801-7D46AAD5-7870-4FCB-8D11-51C27D5B8C1CQ37851768-11E96AEE-6AE7-4DEF-9BB7-A07F19A5680EQ38126554-0855F6B7-664A-44E7-8FEA-DA2EA4A605B1Q38670345-C1139BAD-4853-4C6B-8CA3-6561BD9C46F4Q38904284-2567DAA4-3293-42C4-BF15-D288F2E5DC6DQ39194543-1F9767F5-6C7B-45FF-B24B-E9148AFE2596Q39227661-8C4376AF-DA1A-4A12-ACC3-AA79E4B4916DQ41935426-73C2B5D5-59CA-48BE-A74B-C9535FB7EFC7Q45073135-FDAC422C-62D0-42F7-BF94-B75A3D745B8BQ46171847-8CD33DB9-CB78-4AE4-8338-49617AFAD7BEQ46269647-533A54B0-6899-447C-986A-BEF91DD51408Q46288550-563196A0-4D1A-4065-A0ED-121F62986C2AQ46621430-7CCC3791-331E-4582-B475-8A55E1AEB251Q46934674-E1ED7FD8-2D2F-47BF-BEDF-A9BCE01C4AA4Q46974163-32B61A0C-1379-4B74-BAB6-06BFC7304368Q47266736-4882FBE8-FEEA-44AF-AFF7-4D5F4B6BF9FFQ48194170-CD49AD46-DD0B-4075-A73A-093B6ECFAF36Q49396911-95B1BB50-D6EE-4AE2-B036-B369104CDCCCQ49886715-3497F03D-93CB-4A31-A8FB-AF5404FDB66BQ50965031-1038B404-1866-4124-9969-C27573CB1583Q51277742-FEC5609B-3BC0-4761-8EC2-CF949657AC74Q51529847-82C35A71-EDF3-456A-B4D7-929203451784Q58754705-C063A8DE-A94A-4D07-8619-AF812E9792DCQ58872138-1A71DB72-3304-4180-91D0-13A3B07CDAE5
P2860
Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicity.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Low-intensity exercise trainin ...... otects against cardiotoxicity.
@en
Low-intensity exercise trainin ...... otects against cardiotoxicity.
@nl
type
label
Low-intensity exercise trainin ...... otects against cardiotoxicity.
@en
Low-intensity exercise trainin ...... otects against cardiotoxicity.
@nl
prefLabel
Low-intensity exercise trainin ...... otects against cardiotoxicity.
@en
Low-intensity exercise trainin ...... otects against cardiotoxicity.
@nl
P2093
P2860
P1476
Low-intensity exercise trainin ...... otects against cardiotoxicity.
@en
P2093
Adam J Chicco
Carole M Schneider
David S Hydock
Reid Hayward
P2860
P304
P356
10.1152/JAPPLPHYSIOL.00148.2005
P407
P577
2005-10-06T00:00:00Z